Abstract The role of matrix metalloproteinases (MMPs) in collagen fibrillogenesis during development has been studied in the well-characterized chicken metatarsal tendon. Collagen fibrils are initially assembled as intermediates, and the mature fibrils assemble by linear and lateral growth from these intermediates. We hypothesize that this involves the turnover of fibril-associated molecules mediated by the expression and activation of matrix metalloproteinase-2 (MMP-2). We demonstrate changes in the ratio of fulllength to truncated MMP-2 during tendon development, consistent with enzyme activation. The level of full-length proMMP-2 remains relatively unchanged, although the truncated form of MMP-2 is highest prior to and during fibril growth. Membrane-type matrix metalloproteinase-3 (MT3-MMP, MMP-16) is fibroblast-associated and involved in the regulation of MMP-2 and in direct matrix turnover. The ratio of full-length proMT3-MMP/truncated (active) MT3-MMP has a pattern similar to that of fulllength proMMP-2/truncated (active) MMP-2 during tendon development. Regulation of proMMP-2 activation involves complex formation with active MT3-MMP and TIMP-2. The constantly low TIMP-2 expression seen in tendon development is consistent with this role. Isolation of collagen fibrils from pre-fibril growth tendons (14 day) in the presence of activated MMP-2 is associated with premature fibril growth observed as increased fibril diameters compared with controls. These data implicate MMP-2/MT3-MMP in the initiation and progression of fibril growth, matrix assembly, and tendon development. This may involve the turnover of fibril-associated molecules involved in regulating linear and lateral growth, such as small leucine-rich proteoglycans and fibril-associated collagens. Activation of proMMP-2 dependent on MT3-MMP would allow the focal control of turnover.
embryonic implantation (Fairbairn et al. 1985; Mignatti et al. 1986; Woessner 1994; Birkedal-Hansen 1995; Brinckerhoff and Matrisian 2002) . The MMPs are a family of matrix-degrading proteinases with broad substrate specificity and are capable of degrading virtually all matrix components (Nagase and Woessner 1999; McCawley and Matrisian 2001; Brinckerhoff and Matrisian 2002) . Extracellular matrix turnover and remodeling are slow processes in mature tissues, but matrix remodeling is essential during development and growth. Elucidating the roles of both assembly and turnover during collagen fibrillogenesis and matrix assembly is thus important for developing an understanding of the growth and remodeling of continuously functional connective tissues, such as tendon.
MMP-2 and MMP-9 (gelatinases A and B) show activity against a host of traditional matrix components, including denatured collagen molecules (gelatin) and native fibrillar and non-fibrillar collagens, laminin, aggrecan, and vitronectin (Aimes and Quigley 1995; Woessner and Nagase 2000; McCawley and Matrisian 2001) . MMP-2 (72-KDa gelatinase, gelatinase A) can also degrade decorin (Imai et al. 1997 ) and activate other MMPs and growth factors (McCawley and Matrisian 2001) . Mice deficient in MMP-2 do not display significant deficiencies during development and growth (Itoh et al. 1997) . However, the increased MMP-2 levels observed associated with decreased uptake in the absence of thrombospondin 2 have been related to altered collagen fibril structure and tendon organization during development (Kyriakides et al. 1998; Bornstein et al. 2000 Bornstein et al. , 2004 Yang et al. 2000) .
MMPs with a transmembrane domain (MT-MMPs) are activators of MMP-2 (Takino et al. 1995; Shofuda et al. 1998; Shimada et al. 1999 ). MT3-MMP (MMP-16) is widely expressed and is capable of degrading many extracellular matrix components including type III collagen (Matsumoto et al. 1997; Shimada et al. 1999) . MT3-MMP is localized at the cell surface. Unlike other MMPs, MT-MMPs are rapidly degraded by autolysis after maturation to prevent excess activity, because, unlike other MMPs, these enzymes are intracellularly activated by furin or a similar serine proteinase (Sato et al. 1996) . In situ hybridization has demonstrated that chicken MT3-MMP is expressed at high levels in a number of developing tissues (Yang et al. 1996; Huh et al. 2007 ). The different tissue distributions for the individual MTMMPs suggest tissue-specific roles in extracellular matrix turnover (Shimada et al. 1999) . The MT-MMPs are likely to play important roles in localized hydrolysis and controlled site-specific activation of other MMPs. Activated MMPs are regulated by tissue inhibitors of metalloproteinases (TIMPs). TIMP-2, but not TIMP-1, has been shown to stimulate MT-MMP-mediated activation of MMP-2 on the cell surface. Activation occurs at low TIMP concentrations, because the binding of MMP-2 to MT-MMP increases. However, TIMP inhibits the same processes at higher concentrations when MT1-MMP is saturated by TIMP-2 leaving no free MT-MMP available for MMP-2 activation (Strongin et al. 1995; Butler et al. 1998) . Therefore, cellular activation of MMP-2 is dependent on concentration and on the balance between free MT-MMP and the MT-MMP/TIMP-2 complex (Butler et al. 1998) .
During tendon development, MMPs have a potential role in the turnover of fibril-associated macromolecules involved in the regulation of collagen fibril assembly. Fibrils are initially assembled as short small-diameter intermediates. These immature intermediates are the building blocks of the mature fibril (Birk and Trelstad 1986; Birk et al. 1989 Birk et al. , 1990 Birk et al. , 1991 Birk and Zycband 1994; Kadler et al. 1996; Graham et al. 2000) . Fibril intermediates have been characterized in tendon and other connective tissues, including cornea and dermis (Birk et al. 1989 (Birk et al. , 1995 Holmes et al. 1994) . During tendon development, intermediates are incorporated into fibers and maintained. However, during a narrow period of chicken tendon development (17-18 days), the intermediates mature to form long fibrils of indeterminate length characteristic of the mature, mechanically functional tendon (Birk et al. 1995 . The assembly of intermediates into longer continuous fibrils with larger diameters allows for growth and dramatically increases the tensile strength of tissues such as the tendon. The controlled expression, activation, or inhibition of the MMPs during development may alter the surface of fibril intermediates and/or the interfibrillar matrix, thereby regulating their growth. Decorin, other closely related leucine-rich-repeat proteoglycans, fibrilassociated collagens types XII and XIV, and amino-terminal domains of fibrillar collagens all interact with the fibril surface and have been implicated in the regulation of tendon fibrillogenesis (Birk and Mayne 1997; Iozzo 1999; Ezura et al. 2000; Zhang et al. 2003 Zhang et al. , 2005 . These regulatory matrix macromolecules are all substrates for MMP-2/MT3-MMP, implicating these enzymes in the focal control of the matrix turnover required during tendon development.
In the present study, we have examined the levels of MMP-2 in developing chicken metatarsal tendons. The levels have been analyzed at various periods in the fibril growth phase, i.e., prior to, during, and after the growth phase. Our hypothesis is that tightly regulated, focal MMP activity is required for the linear and lateral growth of fibrils from immature intermediates. This involves MMPs, such as MMP-2 and MT3-MMP, and TIMPs. Our results indicate that the beginning of tendon fibril growth (14 day) is associated with the presence of both full-length and truncated forms of MMP-2 and MT3-MMP, consistent with enzyme activation. The amount of the proforms remains the same, but the truncated forms disappear toward the end of fibril growth (19 day). Ex vivo studies indicate that MMP activity is involved in the removal of a component(s) from the immature fibril surface, thus allowing adjacent fibril intermediates to associate and the fibril growth phase to proceed.
Materials and methods
Extraction of MMPs from metatarsal tendons White Leghorn chicken embryos were obtained from Spafas (Preston, Conn.). For extraction of MMPs, chicken metatarsal tendons were dissected from staged embryos (Hamburger and Hamilton 1951) and washed three times with phosphatebuffered saline (PBS). Soluble proteins were extracted from tendons by homogenization with an extraction buffer containing 50 mM TRIS-HCl pH 8.0, 150 mM NaCl, 1 mM CaCl 2 , 1 μM ZnCl 2 , 0.1% Triton X-100, and 0.05% sodium azide. Homogenates were centrifuged at 13,000 rpm for 30 min at 4°C, and the supernatant was collected. Extracts were analyzed by using zymography and immuno-blots for MMPs. Samples were normalized for total protein or constant wet tendon weight. Protein concentration was determined by using the BCA protein assay reagent (Pierce, Rockford, USA). Normalization for constant wet tendon weight or protein concentration yielded comparable, virtually identical results. During this period of development, tendon cells were non-proliferative (Nurminskaya and Birk 1998) .
Zymography Tendon extracts were analyzed by zymography as reported (Hibbs et al. 1987) . Briefly, SDSpolyacrylamide gels (7.5% or 10%) were prepared, and gelatin (from bovine skin; Sigma, St. Louis, Mo.) or casein (Sigma) was included in the gels at a concentration of 1%. Equal amounts of extract normalized for protein (30 μg) or wet weight were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) under non-reducing conditions. After electrophoresis, the gels were incubated in 2.5% Triton X-100 for 30 min, washed in distilled H 2 O, and then incubated in 50 mM TRIS pH 7.6, 10 mM CaCl 2 , overnight at 37°C. Enzymatic activity was identified after the gel had been stained with Coomassie Brilliant Blue (Sigma).
Collagenase activity for type I collagen Collagenase assays were performed as described previously (Levine et al. 1984) . Samples of tendon extracts normalized for constant wet weight were activated with 2 μg trypsin for 5 min at 37°C, followed by the addition of 2 μg soybean trypsin inhibitor (Sigma). The assays were performed in a final volume of 300 μl containing 30 μg [ 3 H]-collagen, 50 mM TRIS-HCl pH 7.8, 20 mM NaCl, 10 mM CaCl 2 , 20 μg/ml bovine serum albumin (BSA), and 35 μl activated or unactivated tissue samples. The reaction was carried out for 2 h at 37°C in a shaking water bath and terminated by the addition of Na 2 EDTA. To degrade the partially digested collagen further, 100 μg chymotrypsin (Sigma) and 100 μg trypsin (Sigma) were added and incubated for 30 min at 37°C. The reaction was stopped by the addition of 0.4 mg/ml BSA and 1 volume of cold 20% trichloroacetic acid on ice. The undigested collagen in the precipitate was collected on glass-fiber filters and washed, and radioactivity was determined. In each assay, the control samples and the unactivated and activated samples were run in triplicate and processed in parallel. Collagenase activity was expressed as the difference between the control and experimental sample.
Immuno-blot analysis Analyses were performed by using standard techniques (Huh et al. 2007 ). Equal amounts of protein lysates (30 μg) were separated by using SDS-PAGE under non-reducing conditions, and the proteins were transferred electrophoretically onto nitrocellulose membranes (0.2 μm; Schleicher and Schuell). The membranes were blocked in the presence of 5% non-fat dry milk in TRISbuffered saline containing 0.1% Tween-20 (TBS-T) for 1 h to minimize non-specific binding. Antibodies against MMP-2 were purchased from Chemicon (Temecula, Calif.), against MT3-MMP from Calbiochem (San Diego, Calif.), and against TIMP-2 from Sigma. Primary antibodies were diluted in TBS-T containing 5% dry milk, incubated with the samples for 1 h, and detected by using a horseradish peroxidase (HRP)-conjugated anti-rabbit IgG or goat antimouse IgG for 1 h. Specific antibody binding was visualized by means of an enhanced chemiluminescence detection kit (Amersham, Biosciences) with X-ray film exposure.
Ex vivo studies of fibril growth Metatarsal tendons were dissected from 14-day-old White Leghorn embryonic chickens, and cultures were established as previously described (Doane and Birk 1991) . Briefly, tendons were incubated with 200 U/ml bacterial collagenase (Sigma) in minimal essential medium (MEM; Gibco Laboratories) with sodium bicarbonate buffer, 50 μg/ml gentamicin, and 2.5 μg/ml fungizone (CMEM) for 2 h at 37°C, with trypsin being added to give a final concentration of 0.25% after 1 h. Tendons were filtered through a Swinex filter with Spectropor mesh (105 μm). The cell suspension was centrifuged at 1,000 rpm for 5 min, and the pellets were resuspended in MEM with 20% fetal bovine serum and plated in tissue culture flasks with 10% fetal bovine serum in MEM, with 0.05 mg/ml ascorbate being added to the medium after 48 h. The cultures were washed three times with serum-free MEM followed by culture for 24 h in serumfree medium. The conditioned medium was collected, centrifuged to remove cell debris, and stored frozen. Prior to use, the conditioned medium was activated with 1 mM aminophenylmercuric acetate.
The effects of MMP-2 on fibril growth were analyzed after the isolation of tendon fibrils with conditioned or control media. Activated medium was treated with aminophenylmercuric acetate and contained predominately MMP-2 activity. Controls included activated media with EDTA, a non-specific MMP inhibitor, and MEM. Fibril intermediates were isolated from 14-day-old chicken embryo tendons essentially as described (Birk et al. 1995 . Briefly, White Leghorn chicken embryos were obtained from Spafas (Preston, CT) and staged (Hamburger and Hamilton 1951) . Metatarsal tendons at 14 days of development were dissected and washed in PBS (pH 7.2) at 4°C followed by homogenization in conditioned or control culture media with a Dounce homogenizer. The tendon homogenate was incubated in the respective media for a total of 4 h at 37°C and centrifuged at 16,000g for 20 s. The supernatant containing the extracted fibrils was removed and analyzed. The fibrils present at this stage of tendon development were homogeneous, with small diameters (Birk et al. 1990 (Birk et al. , 1995 Birk and Mayne 1997; Ezura et al. 2000) .
Fibrils treated with conditioned media or control preparations were analyzed by transmission electron microscopy. Fibrils were absorbed onto butvar/carbon-coated grids. The grids were washed with PBS and negatively stained with 1% phosphotungstic acid (pH 7.0). Specimens were then examined and photographed by means of a Philips CM10 transmission electron microscope operating at 80 kV. Calibrated micrographs were randomly selected from each experimental group in a masked manner. Fibril diameters were measures from six independent groups. The differences between the experimental and each control group were analyzed by using a t-test.
Fibril diameters also were determined from day-14 and day-20 chicken embryo tendons. Tendons were processed for electron microscopy as previously described (Birk and Trelstad 1986) . Fibril diameters were measured from transverse sections as previously described (Ezura et al. 2000) .
Results

MMP-2 expression in developing tendons
The MMPs present in tendon extracts and the developmental patterns of appearance were analyzed using gelatin zymograms. Extracts from both 14-day and 19-day tendons contained a band of zymogram activity with a mobility of 70 kDa consistent with proMMP-2. In addition, a second gelatinolytic band was present with a lower mobility, about 8 kDa less in apparent molecular weight, consistent with the truncated active form of MMP-2 (Fig. 1a) . In the 14-day and 19-day tendon extracts, proMMP-2 was observed in comparable amounts. In contrast, the truncated form of MMP-2 predominated in 14-day tendon extracts. The 14-day tendon extracts contained approximately five-fold more of the activated form than the 19-day extracts. In addition, no 92-kDa gelatinase activity, consistent with MMP-9, was detected at either stage of tendon development. Positive controls consisting of medium conditioned by rabbit corneal fibroblasts and containing MMP-9 were included on the zymograms (data not shown; Matsubara et al. 1991) .
The identities of the gelatinolytic activities with a relative mobility of~70 kDa and~62 kDa, observed by zymography, were confirmed by using immuno-blot analysis and an antibody against MMP-2 (Fig. 1b) . The immuno-blots showed reactivity of the putative proMMP-2 and MMP-2 bands with the anti-MMP-2 antibodies, thus confirming their identity. Higher-molecular-weight bands reactive with anti-MMP-2 antibody were present with approximately equal densities in both 14-day and 19-day tendon extracts. These bands possibly represented proMMP-2 complexes with other molecules. In addition, lower-molecular-weight MMP-2-reactive bands were observed. These probably represented degradation products with the faster-migrating bands representing the MMP-2 pro-domain. Consistent with the zymogram, no reactivity was observed with antibodies against MMP-9 (data not shown).
To define the developmental expression pattern of MMP-2, tendon extracts were analyzed between embryonic days 14 and 20 by using zymography. As shown in Fig. 2 , there was a significant decrease in the ratio of proMMP-2/ truncated MMP-2 activity from 14 to 19 days of tendon development, consistent with enzyme activation. The ratio of MMP-2 forms was further defined relative to stages in tendon fibril growth. A ratio consistent with enzyme activity was highest in tendons from 14-day embryos. At day 15, a consistent decrease in the activity ratio was Fig. 1 Alteration in the ratio of full-length to truncated MMP-2 forms in developing tendons. a Gelatinolytic activities from tendon extracts from 14-day and 19-day chicken embryos were analyzed by zymography on gelatin-containing 10% SDS-polyacrylamide gel (SDS-PAGE) gels. Activity with a relative mobility consistent with proMMP-2 and activated MMP-2 was present in extracts from both 14-day and 19-day tendons. No activity was present corresponding to MMP-9 (92-kDa gelatinase) at either developmental stage. b Immunoblot analysis of extracts from developing tendon was performed to confirm the identity of the activities consistent with proMMP-2 and MMP-2 on gelatin zymograms. The immuno-blot analysis by 7.5% SDS-PAGE with an antibody against MMP-2 demonstrated that these activities were proMMP-2 and MMP-2. Higher-molecular-weight bands possibly representing complexes with MT3-MMP and TIMP-2 (*) were observed, as were lower-molecular-weight MMP-2-reactive bands possibly representing proMMP-2 degradation products (**). MW standards (kDa) were included b observed. The activity ratio reached a plateau and remained high between day 15 and day 18 of tendon development (prefibril growth and growth phase). The activity ratio decreased significantly from 18 to 20 days of development. A plateau occurred at a low enzyme level in 19-day and 20-day tendons. Across all developmental stages studied (days 14-20), the proMMP-2 activity band was low and comparable. The observed differences in band ratio were primarily attributable to changes in activated MMP-2.
Type I collagenolytic and MMP-3 activity in developing tendons Type I collagenolytic activity was determined at 14 days and 19 days of tendon development. Both 14-day and 19-day tendon extracts exhibited type I collagenolytic activity, the activity from 14-day tendons being greater than that from 19-day, both in tendon extracts that were untreated or treated with soybean trypsin inhibitor to activate latent enzyme. The differences were approximately five-fold in unactivated extracts, and more than two-fold in activated extracts (Fig. 3) . The expression pattern was similar to that . Tendon extracts between 14-and 20-days of development were analyzed on gelatin zymograms. All tendon extracts contained both proMMP-2 and MMP-2 activity. An approximately 30% decrease occurred in proMMP-2 activity from day 14 to day 15 of development. Between day-15 and day-20, proMMP-2 levels were comparable. The activity of MMP-2 decreased with development. Its activity was highest proceeding and during the fibril growth phase (14-18 days) but decreased significantly after the period of rapid fibril growth (19-20 days). The amount of extract loaded was normalized to constant wet tendon weight. When normalized to constant DNA or protein, nearly identical results were obtained. Three to five independent experiments were carried out for each developmental stage (±SEM) of MMP-2. To analyze MMP-3 (stromelysin) in tendons during the various stages of development, extracts underwent electrophoresis on casein zymograms. Both 14-day and 19-day tendons contained easily detectable levels of caseinolytic activity. However, this corresponded to MMP-2, with no activity being seen in the~45-55-kDa range expected of mammalian MMP-1 (collagenase)/ MMP-3 (stromelysin) enzymes (data not shown). In addition, zymograms were prepared by using fibronectin, laminin, and a mixture of decorin and lumican, viz., matrix components that are all substrates for mammalian MMP-3. However, chicken tendon extracts demonstrated no activity in the~45-55-kDa range. This was in contrast to the mammalian enzyme, included as a positive control, that demonstrated activity with an apparent molecular weight of 51 kDa (data not shown).
MT3-MMP (MMP-16) and TIMP expression correlates with MMP-2 activation in developing tendon
High activity levels of MMP-2 identified on zymograms and confirmed by immuno-blot analysis (Fig. 1) were associated with the period of rapid fibril growth at 14-18 days of development. During development, the activation of MMPs must be a tightly controlled process, with the focal control of activation involving cell-surface-associated MT-MMPs and TIMPs. MT3-MMP protein expression was therefore analyzed by using immuno-blots to address its role in the regulation of MMP-2 activation (Fig. 4a) . Both proMT3-MMP and MT3-MMP were detected in 14-day and 19-day tendon extracts. Increased levels of the active form, intermediate forms, and the proform of MT3-MMP were consistently observed in 14-day compared with 19-day tendon extracts. In addition, strong reactivity with high-molecular-weight forms of MT3-MMPs were only detected in 14-day tendon extracts. These forms remain unidentified but may represent complexes of MT3-MMP with proMMP-2 and/or TIMP-2. Moreover, relatively weak reactivity with low-molecular-weight forms (presumably the result of autolysis) were also only detected in extracts from 14-day tendon. Based on high levels of truncated MT3-MMP, we postulate that MT3-MMP is involved in converting proMMP-2 to active MMP-2 during the transition to fibril growth in the developing tendon.
TIMP-2 expression was investigated at 14 and 19 days of tendon development by using immuno-blot analysis. TIMP-2, but not TIMP-1, was shown to stimulate MT-MMP-mediated activation of proMMP-2 on the cell surface at low concentration (Strongin et al. 1995; Butler et al. 1998) . The level of TIMP-2 expression was comparable in both day-14 and day-19 tendon extracts (Fig. 4b) . This is consistent with a potential role of TIMP-2 in proMMP-2 activation. At low concentrations of TIMP-2, proMMP-2 activation is probably positively regulated by TIMP-2 in the presence of high levels of MT3-MMP expression at day 14, compared with at day 19.
MMPs initiate lateral fibril growth ex vivo
To address the role of MMP-2 in tendon fibrillogenesis, fibrils from 14-day chicken embryos were isolated in MMP-2-containing conditioned medium. Like the tendon extracts, the conditioned medium from 14-day tendon fibroblasts contained predominantly MMP-2 activity (Fig. 5a, b) . No MMP-9 or other activity was observed on using gelatin and casein zymography. Chicken tendons at 14 days of development were composed of a homogeneous population of small-diameter fibrils. In contrast, 19-21 day tendons contained a heterogeneous population of largerdiameter fibrils undergoing lateral growth associated with the maturation of the tendon (Fig. 5c, d) . The presence of MMP-2 during fibril isolation yielded fibrils that were in the lateral fibril growth stage, whereas fibrils isolated in the absence of MMPs or with MMPs and EDTA had not started fibril growth (Fig. 5e, f) . The isolated fibrils under all Fig. 3 Characterization and developmental expression of collagenase. Type I collagenolytic activity from tissue extracts of 14-day (14D) and 19-day (19D) tendons. Both the activated and unactivated samples contained increased type I collagenase activity at 14 days relative to 19 days of development. Equal amounts of sample relative to tendon wet weight were activated by treatment with trypsin. Reaction mixtures containing enzyme from the tissue extracts and [ 3 H]-labeled type I collagen were incubated for 2 h at 37°C, followed by digestion of the partially degraded collagen substrate with trypsin and chymotrypsin. The undigested collagen was precipitated with trichloroacetic acid, and the percent digestion was determined. Collagenase activity was expressed as the percent of control samples. At least three different experiments were carried out for each stage (±SEM) conditions were intact with a characteristic 67-nm banding pattern. The fibrils isolated in control media, with no MMP-2 or inactive MMPs, had mean diameters of 35.8±7.9 nm (24-58 nm) and 39.4±6.9 nm (21-66 nm), respectively ( Fig. 5f ). In addition, the fibril diameter distribution was symmetric and characteristic of that seen in 14-day tendons. However, fibrils isolated in the presence of active MMP-2 had significantly larger diameters than in the absence of MMP-2, i.e., in MEM (P<0.001) or activated media with EDTA (P<0.01). These fibrils had mean diameters of 46.3 ±9.5 nm (26-75 nm). The fibril diameter distribution was not symmetric but was skewed to the right, i.e., had larger diameters and a broader range. These data were comparable with those seen in 20-day tendons when fibril growth had occurred (Fig. 5h) .
Discussion
The role of MMPs in collagen fibrillogenesis during tendon development was studied by using the well-characterized chicken metatarsal tendon model. Our studies demonstrated significant changes in the ratio of MMP-2 full-length proforms to truncated active forms during tendon development consistent with changes in enzyme activity; this was correlated with entrance into and progression through the fibril growth stages (periods of rapid matrix assembly and tendon growth). The ratio of truncated to full-length MMP-2 and MT3-MMP was higher prior to and during fibril growth than at the later stages characteristic of mature fibrils. This correlation implicates MMP-2/MT3-MMP in the initiation of and progression of normal collagen fibril growth, matrix assembly, and tissue development.
Our data demonstrate high levels of MMP-2 activity associated with tendon fibril growth suggesting a key role for MMP-2 in this important developmental event. The thrombospondin 2-deficient mouse exhibits an abnormal increase in MMP-2 activity. This altered expression pattern is associated with changes in cellular and matrix organization and in abnormal collagen fibril structure in the developing tendon (Bornstein et al. , 2004 Yang et al. 2001 ). The fibrils have larger diameters and irregular contours (Kyriakides et al. 1998 ) consistent with altered lateral fibril growth. This dysfunctional regulation is consistent with our data indicating abnormal lateral growth when 14-day fibrils are isolated in the presence of MMP-2. These data support an important role for regulated MMP-2 activation during tendon development. Our conclusions are not supported by findings from the MMP-2-deficient mouse model in which growth is not significantly impacted (Itoh et al. 1997 ). However, the potential compensation by other MMPs in the absence of MMP-2 cannot be excluded in this model.
The ratio of MT3-MMP forms has a similar pattern to that observed for MMP-2, i.e., more truncated form at 14 days than at 19 days of tendon development. The Fig. 4 Immuno-blot analysis of MT3-MMP and TIMP-2 in tendon development. MT3-MMP and TIMP-2 expression at 14 and 19 days of development by using immuno-blot analysis of tendon extracts. a Both ProMT3-MMP (63 kDa) and MT3-MMP (54 kDa) were expressed at both developmental stages. However, significantly higher expression of MT3-MMP occurred at 14 days (14D) compared with 19 days (19D) of tendon development. Both higher-molecular-weight bands (that may represent complexes of MT3-MMP with MMP-2 and/ or TIMP-2) and barely detectable low-molecular-weight reactivity (presumably autolytic products; arrowheads) were only observed in extracts from 14-day tendons. b The expression of TIMP-2 in the 14-day and 19-day tendon extracts also was analyzed. A band migrating at approximately 20 kDa consistent with TIMP-2 was observed at both developmental stages. TIMP-2 was expressed in comparable amounts at both developmental stages. The data suggest that MT3-MMP and TIMP-2 at the cell surface focally regulate MMP-2 activation, thereby providing a mechanism for focal degradation directly influenced by the cell in developing tissues. MW standards (kDa) are included observed developmental changes correlate with the amount of MMP-2 truncated form detected in tendon extracts. Since the proMMP-2 levels are relatively constant, this suggests that the activation of MMP-2 is the regulatory step. Our data suggest a role for MT3-MMP in the activation of proMMP-2 during tendon development. The proMMP-2 binds to TIMP-2 bound to MT-MMP by forming a complex at the cell surface where the uninhibited free MT-MMP then cleaves and partially activates the tethered proMMP-2 (Strongin et al. 1995; Deryugina et al. 1997; Nagase 1998) . A residual portion of the MMP-2 propeptide is removed by another MMP-2 molecule at the cell surface to To determine whether MMP-2 was sufficient to initiate fibril growth, fibrils were isolated and analyzed from 14-day tendons in the presence of activated conditioned medium, activated medium with the non-specific MMP inhibitor EDTA, and control media. The conditioned medium contained primarily MMP-2 and its precursor form as shown by gelatin (a) and casein (b) zymography. Electron micrographs of fibrils in transverse sections from 14-day (c, 14D) and 20-day (d, 20D) tendons showed that the pre-fibril growth tendons contained a homogeneous population of small-diameter fibrils (c), whereas the post-fibril growth tendon had a heterogeneous distribution of largerdiameter fibrils (d). The diameters of the fibers were determined from such transverse sections (c, d), the distributions being presented graphically (blue in f, h). All fibrils isolated in control (e) and activated (g) media were intact with the characteristic 67-nm banding pattern (e, g). However, the fibrils isolated in the presence of MMP activity were consistently larger in diameter. The mean diameters of fibrils isolated in the control and activated media with EDTA (f) were significantly smaller than fibrils isolated in medium containing activated MMP-2 (h, P<0.001 and P<0.01, respectively). The fibrils isolated in control medium in which MMP activity was low or absent were smaller than the fibrils isolated in the presence of MMPs. In addition to the shift to larger diameters, the distribution of fibril diameter from tendons isolated with activated MMPs developed a significant right-hand shoulder relative to the control distribution. This shoulder contained larger-diameter fibrils. The right-hand shift of the distribution and development of a shoulder with large-diameter fibrils was characteristic of tendons during fibril growth. These distributions were comparable with those seen in normal tendon development at 14 and 20 days (blue) of development (Activated Media conditioned medium from 14-day tendon fibroblasts treated with 1 mM aminophenylmercuric acetate, Control MEM not incubated with fibroblasts, Activated Media + EDTA conditioned medium with 10 mM EDTA as a non-specific inhibitor of MMP activity) yield the fully active, mature form of MMP-2 that can then be released from the cell surface. Active MMP-2 can also be inhibited by another TIMP-2 molecule or left in an uninhibited active state depending on local MMP-2:TIMP-2 molar ratios (Strongin et al. 1995; Deryugina et al. 1997; Nagase 1998) . In normal developing tendon in vivo, we assume that TIMP-2 expression levels at day 14 are low enough to activate MMP-2, because high levels of both active MMP-2 and MT3-MMP have been detected. Our data also demonstrate relatively low TIMP-2 concentrations, presumably at levels that favor MMP-2 activation, but constant expression of TIMP-2 across the developmental period studied. During tendon development, this correlation between MMP-2 activity and MT3-MMP expression level and the constantly low expression of TIMP-2 indicate that the matrix turnover involved in the regulation of fibrillogenesis is regulated focally.
MT-MMPs are capable of degrading many extracellular matrix components including native collagen, adhesive glycoproteins, and growth factors (d'Ortho et al. 1997) . The degradation of collagen type III is highly efficient with MT3-MMP (Matsumoto et al. 1997; Shimada et al. 1999) . Type III collagen is expressed early in chicken tendon development, during the initial assembly of fibril intermediates, but prior to fibril growth steps (Birk and Mayne 1997) , and the removal of type III collagen has been proposed to be required prior to linear and lateral fibril growth. Taken together, our studies suggest that MT3-MMP plays an important role in extracellular matrix turnover, not only by activating MMP-2, but also by acting directly on extracellular matrix macromolecules, including type III collagen. Our results demonstrate a collagenase activity with an expression pattern similar to the MMP-2. Collagenase (MMP-1) can degrade fibrillar collagens and others and promote the activation of MMP-2 (Crabbe et al. 1994) . Potentially, these MMPs might work together to facilitate the turnover of type III collagen and other matrix components. Alternatively, the reported collagenase activity could be the result of the known collagenolytic activity of both MMP-2 (Aimes and Quigley 1995) and MT3-MMP (Shimada et al. 1999) . Our model of fibrillogenesis, from preformed intermediates, does not include the turnover of entire collagen fibrils, only associated molecules. Therefore, we favor the latter explanation in which the collagenase activity present is secondary to the activity required for the turnover of fibril-associated molecules.
The data suggest that MT3-MMP has crucial roles in tissue remodeling during tendon development, both as an activator of proMMP-2 and as a membrane-associated enzyme capable of degrading a spectrum of extracellular matrix molecules. In addition, its presence at the fibroblast surface provides a mechanism for localizing MMP-2 activity. Therefore, MT3-MMP provides turnover directly, local activation of other enzymes, and the compartmentalization of these processes at the fibroblast surface. These important functions suggest that MT3-MMP is a key regulator of matrix turnover during development. Data obtained from the MT1-MMP-deficient mouse support this suggestion. In this model, in which MMP-2 and TIMP-2 are normal, severe developmental defects occur in a spectrum of connective tissues, including bone, cartilage, teeth, and soft connective tissues (Holmbeck et al. 1999 (Holmbeck et al. , 2004 Zhou et al. 2000) . Postnatal growth is severely affected in the MT1-MMP-deficient mice. In mice, the stage of linear and lateral fibril growth begins around postnatal day 10 (Ezura et al. 2000; Zhang et al. 2005) , and presumably the coordinate activity of MMP-2 and MT3-MMP is involved in the regulation of this transition.
Our previous studies of tendon fibril growth have demonstrated that the fibril intermediate is the precursor to the mature continuous collagen fibril. Day-14 embryonic tendons are composed of small-diameter short (~10 μm) fibril intermediates (Birk et al. 1989 ). This is a rapidly growing stage with a high rate of collagen synthesis and fibril assembly. From days 14 to 19, the fibril intermediates increase in length and diameter, forming mature fibrils (Birk et al. 1995 . We hypothesize that fibril growth involves lateral associations and fusion of intermediates associated with an alteration in the fibril surface and/or interfibrillar matrix (Birk et al. 1995) . In the chicken, from day 14 to day 20, changes occur in a number of fibrilassociated molecules including type III collagen (Birk and Mayne 1997) , decorin (Birk et al. 1995) , fibromodulin (Nurminskaya and Birk 1996) , and type XIV collagen (Young et al. 2000) . We have been unable to detect stromelysin-1 activity during this period of tendon development. This enzyme shows activity with numerous fibril-associated and interfibrillar molecules, including proteoglycans and fibril-associated collagens (McCawley and Matrisian 2001) . MMP-2 and MT3-MMP have broad substrate specificity, including the fibril-associated molecules or members of these classes found in developing tendon (Imai et al. 1997; Woessner and Nagase 2000; McCawley and Matrisian 2001) . This substrate specificity of MMP2/MT3-MMP and the lack of stromelysin further support the role of the former in matrix turnover during tendon fibrillogenesis.
Overall, the present data indicate that collagen fibril growth during chicken tendon development, both in vivo and in vitro, involves MMP-2-dependent mechanisms. Our data implicate MMP-2/MT3-MMP in the initiation and progression of collagen fibril growth, matrix assembly, and tendon development. This might involve the turnover of fibril-associated molecules associated with regulating linear and lateral fibril growth, such as small leucine-rich proteoglycans and fibril-associated collagens. Turnover dependent on the activation of proMMP-2 by fibroblastassociated MT3-MMP would allow for the regulated focal control of turnover.
